One World Products (OWPC) 10-Q 12 Jun 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	Jun. 10, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-56151
Entity Registrant Name	ONE WORLD PRODUCTS, INC.
Entity Central Index Key	0001622244
Entity Tax Identification Number	61-1744826
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	6605 Grand Montecito Pkwy
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89149
City Area Code	(800)
Local Phone Number	605-3210
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		104,329,919

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 40,648	$ 726
Accounts receivable	282
Inventory	26,257
Prepaid expenses	31,654	13,156
Total current assets	98,841	13,882
Security deposits	85,000	85,000
Total Assets	183,841	98,882
Current liabilities:
Accounts payable	618,956	528,645
Accrued expenses	871,836	939,368
Dividends payable	211,650	196,734
Total current liabilities	1,970,772	3,872,111
Notes payable, related parties, long-term portion, net of $9,729 of debt discounts at March 31, 2024	2,441,252	1,146,500
Total Liabilities	4,412,024	3,872,111
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value, 9,200,000 shares authorized; no shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively
Common stock, $0.001 par value, 300,000,000 shares authorized; 111,092,849 and 79,827,618 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	111,093	79,828
Additional paid-in capital	19,646,892	18,414,456
Subscriptions payable	69,695	45,000
Accumulated other comprehensive income		42,328
Accumulated (deficit)	(28,630,708)	(26,929,686)
Total Stockholders’ Equity (Deficit)	(8,803,028)	(8,348,074)
Total Liabilities and Stockholders’ Equity (Deficit)	183,841	98,882
Series A Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	997,330	997,330
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	3,577,515	3,577,515
Related Party [Member]
Current liabilities:
Convertible note payable, related party, current maturities		750,000
Notes payable		1,146,500
Notes payable, related parties, long-term portion, net of $9,729 of debt discounts at March 31, 2024	2,441,252
Nonrelated Party [Member]
Current liabilities:
Notes payable	268,330	310,864
Notes payable, related parties, long-term portion, net of $9,729 of debt discounts at March 31, 2024

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Debt discount current	$ 126,670	$ 24,136
Debt discount non current	$ 9,729
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	9,200,000	9,200,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	111,092,849	79,827,618
Common stock, shares outstanding	111,092,849	79,827,618
Series A Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	500,000	500,000
Temporary equity shares issued	99,733	70,233
Temporary equity, shares outstanding	99,733	70,233
Preferred stock, shares authorized	10,000,000
Series B Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	600,000	600,000
Temporary equity shares issued	238,501	272,168
Temporary equity, shares outstanding	238,501	272,168

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 282	$ 2,101
Cost of goods sold	49	967
Gross loss	233	1,134
Operating expenses:
General and administrative	198,847	347,297
Professional fees	578,671	103,848
Depreciation expense		7,857
Total operating expenses	777,518	459,002
Operating loss	(777,285)	(457,868)
Other income (expense):
Loss on early extinguishment of debt	(724,086)
Loss on deconsolidation of foreign subsidiaries	(97,672)
Interest expense	(101,979)	(58,070)
Total other expense	(923,737)	(58,070)
Net loss	(1,701,022)	(515,938)
Other comprehensive loss:
Gain (loss) on foreign currency translation	(42,328)	184,969
Net other comprehensive loss	(1,743,350)	(330,969)
Series A convertible preferred stock declared ($0.60 per share)	(14,916)	(12,773)
Net loss attributable to common shareholders	$ (1,758,266)	$ (343,742)
Weighted average number of common shares outstanding - basic	86,930,048	68,702,907
Weighted average number of common shares outstanding - diluted	86,930,048	68,702,907
Net loss per share - basic	$ (0.02)	$ (0.01)
Net loss per share - diluted	(0.02)	(0.01)
Dividends declared per share of common stock	$ 0	$ 0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Series A Convertible Preferred Stock [Member]
Shares issued price per share	$ 0.60	$ 0.60

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscriptions Payable [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 702,330	$ 4,082,520	$ 67,203	$ 17,123,603		$ (50,699)	$ (22,976,365)	$ (5,836,258)
Balance, shares at Dec. 31, 2022	70,233	272,168	67,202,907
Amortization of common stock options issued for services				38,130				38,130
Series A convertible preferred stock dividend declared				(12,773)				(12,773)
Gain on foreign currency translation						184,969		184,969
Net loss							(515,938)	(515,938)
Series A Convertible Preferred Stock sold for cash	$ 150,000
Series A Convertible Preferred Stock sold for cash, shares	15,000
Series A Convertible Preferred Stock issued for services	$ 45,000
Series A Convertible Preferred Stock issued for services, shares	4,500
Common stock sold for cash			$ 3,000	297,000				300,000
Common stock sold for cash, shares			3,000,000
Balance at Mar. 31, 2023	$ 897,330	$ 4,082,520	$ 70,203	17,445,960		134,270	(23,492,303)	(5,841,870)
Balance, shares at Mar. 31, 2023	89,733	272,168	70,202,907
Balance at Dec. 31, 2023	$ 997,330	$ 3,577,515	$ 79,828	18,414,456	45,000	42,328	(26,929,686)	(8,348,074)
Balance, shares at Dec. 31, 2023	99,733	238,501	79,827,618
Common Stock issued for services			$ 7,150	460,236	24,695			492,081
Common stock issued for services, shares			7,149,621
Common Stock issued for debt commitment fees			$ 2,750	80,543				83,293
Common Stock issued for debt commitment fees, shares			2,750,000
Common stock issued to debt holder in escrow, to be cancelled			$ 10,394	(10,394)
Common stock issued to debt holder in escrow, to be cancelled, shares			10,394,610
Common stock issued pursuant to debt modifications			$ 10,971	713,115				724,086
Common stock issued pursuant to debt modifications, shares			10,971,000
Amortization of common stock options issued for services				3,852				3,852
Series A convertible preferred stock dividend declared				(14,916)				(14,916)
Gain on foreign currency translation						(42,328)		(42,328)
Net loss							(1,701,022)	(1,701,022)
Balance at Mar. 31, 2024	$ 997,330	$ 3,577,515	$ 111,093	$ 19,646,892	$ 69,695		$ (28,630,708)	$ (8,803,028)
Balance, shares at Mar. 31, 2024	99,733	238,501	111,092,849

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Preferred stock dividends per share	$ 0.60	$ 0.60

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (1,701,022)	$ (515,938)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense		7,857
Loss on early extinguishment of debt	724,086
Amortization of debt discounts	46,030
Series A preferred stock issued for services		45,000
Common stock issued for services	492,081
Stock options issued for services	3,852	38,130
Decrease (increase) in assets:
Accounts receivable	(282)	1,673
Inventory	(26,257)	(225,037)
Other current assets	(18,498)	(27,353)
Other assets		(7,023)
Right-of-use assets		22,242
Security deposits		(16)
Increase (decrease) in liabilities:
Accounts payable	90,311	(50,344)
Accrued expenses	139,949	171,267
Deferred revenues		(1,694)
Lease liability		(20,747)
Net cash used in operating activities	(249,750)	(561,983)
Cash flows from investing activities
Purchase of fixed assets		(5,046)
Net cash used in investing activities		(5,046)
Cash flows from financing activities
Proceeds from notes payable, related parties	347,000
Proceeds from notes payable	285,000
Repayments of notes payable	(300,000)
Proceeds from sale of preferred and common stock		450,000
Net cash provided by financing activities	332,000	450,000
Effect of exchange rate changes on cash	(42,328)	190,722
Net increase (decrease) in cash	39,922	73,693
Cash - beginning	726	11,016
Cash - ending	40,648	84,709
Supplemental disclosures:
Interest paid	10,500	22,192
Income taxes paid
Non-cash investing and financing transactions:
Dividends payable	14,916	12,773
Value of debt discounts attributable to commitment shares to related parties	9,839
Value of debt discounts attributable to commitment shares	$ 73,454

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1 – Nature of Business and Significant Accounting Policies Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, the Company entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., a wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian Simplified Shares Company (“OWP SAS”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP SAS) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP SAS. OWP SAS is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). The Company plans to be a producer of and/or source raw and processed cannabis and hemp plant ingredients for both medical and industrial uses across the globe. The Company has received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, the Company is one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, the Company has entered into agreements with local farming cooperatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. The Company began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. OWP SAS has generated revenue since the second quarter of 2020. During the first quarter of 2022, the Company made payments of approximately $ 1,400,000 Bogot On December 22, 2023, OWP SAS, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. In connection with the Reorganization Proceedings, we paused production and sales of our cannabis operations in Colombia until the court overseeing the Reorganization Proceedings (the “Court”) provides the Company with a plan of reorganization, at which time the Company intends to resume operations and satisfy its obligations in Colombia in accordance with the Court’s plan. Furthermore, we continued our aggressive cost-cutting actions that included significant personnel reductions . Reorganization Proceedings Upon the date that the Proposed Plan, which is yet to be determined and remains subject to Court approval, becomes effective (the “Effective Date”), and subject to the effectiveness of the Proposed Plan, it is contemplated that the near term operations of the Company (also referred to as the “Post-Effective Date Debtors”) will consist of (a) claims administration under the Proposed Plan, (b) addressing the litigation, (c) prosecuting, pursuing, compromising, settling, or otherwise disposing of other retained causes of action, (d) defending the Company against any counterclaims, (e) attempting to realize value, if any, from our assets and (f) satisfying other regulatory requirements. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) In the future, the Post-Effective Date Debtors expect to explore potential business opportunities, including strategic partnerships, including those designed to maximize the Debtor’s assets, including restoration of the Company’s cannabis operations. No assurance can be made that the Proposed Plan will become effective or that we will be successful in prosecuting any claim or cause of action or that any strategic alternative will be identified and/or would result in profitable operations. In accordance with ASC 810-10-15, the Company has deconsolidated its foreign subsidiaries until it emerges from the Reorganization Proceedings to include the petitioning entity, OWP SAS, as well as the Company’s non-operating shell entities, Agrobase, S.A.S. and Hope Colombia, S.A.S., given the lack of independently identifiable operations. The deconsolidation resulted in a loss on deconsolidation of foreign subsidiaries in the amount of $ 97,672 1,564,823 During March of 2024, the Company, through OWP Ventures, began to sell a CBD-based therapeutic product in the United States in limited quantities. Financial Reporting Under Reorganization The Unaudited Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q have been prepared to reflect the application of Financial Accounting Standards Board, or “FASB” Accounting Standards Codification, or “ASC” 852, Reorganizations, protection under Colombian Law 1116 of 2006 Effective as of the Petition Date, the Company ceased recognizing interest income on intercompany loans made to the foreign subsidiaries. Subsequent loans advanced to, or payments made on behalf of these foreign subsidiaries, have been recognized as a loss on deconsolidation of foreign subsidiaries. In connection with the Company’s emergence from the bankruptcy protection under Colombian Law 1116 of 2006 Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2024: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada. Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings. Foreign Currency Translation The functional currency of the Company is Colombian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues in the current period consisted of the sale of our CBD rub, and in the prior period revenues consisted entirely of the sale of seeds. The sale of seeds included multi-element arrangements whereby the Company collected 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company had a right of first refusal to purchase products resulting from the harvest. Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance. Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In December 2023 , FASB issued “Income Taxes (Topic ): Improvements to Income Tax Disclosures,” , There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going Concern As shown in the accompanying condensed consolidated financial statements as of March 31, 2024, our balance of cash on hand was $ 40,648 1,871,931 28,630,708 In the event sales do not materialize at the expected rates, management would seek additional financing and would attempt to conserve cash by further reducing expenses. There can be no assurance that we will be successful in achieving these objectives; therefore, without sufficient financing it would be unlikely for the Company to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. The condensed consolidated financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Our ability to scale production and distribution capabilities and further increase the value of our brands, is largely dependent on our success in raising additional capital. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Deconsolidation of Foreign Subs

Deconsolidation of Foreign Subsidiaries	3 Months Ended
	Mar. 31, 2024
Deconsolidation Of Foreign Subsidiaries
Deconsolidation of Foreign Subsidiaries	Note 3 – Deconsolidation of Foreign Subsidiaries On December 22, 2023, our wholly-owned subsidiary, One World Products, S.A.S., a Colombian Simplified Shares Company, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. 1.2 97,672 1,564,823 Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2024 2023 Assets Current assets: Cash $ 3,804 $ 1,660 Inventory 45,616 45,791 Other current assets 48,231 2,687 Total current assets 97,651 50,138 Other assets 225,348 226,542 Fixed assets, net 2,333,021 2,346,281 Total Assets $ 2,656,020 $ 2,622,961 Liabilities and Stockholders’ Equity (Deficit) Current liabilities: Accounts payable $ 396,773 $ 392,403 Accrued expenses 472,606 482,587 Notes payable 182,183 183,148 Intercompany liabilities owed to OWP Ventures, Inc. 7,528,031 7,348,034 Total current liabilities 8,579,593 8,406,172 Stockholders’ Equity (Deficit): Accumulated other comprehensive income 5,463 - Accumulated (deficit) (5,929,036 ) (5,783,211 ) Total Stockholders’ Equity (Deficit) (5,923,573 ) (5,783,211 ) Total Liabilities and Stockholders’ Equity (Deficit) $ 2,656,020 $ 2,622,961 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS For the Three Months Ended March 31, 2024 Operating expenses: General and administrative $ 77,866 Professional fees 14,966 Depreciation expense 13,260 Total operating expenses 106,092 Operating loss (106,092 ) Other income (expense): Interest expense (39,733 ) Total other expense (39,733 ) Net loss $ (145,825 ) Other comprehensive loss: Gain on foreign currency translation $ 5,463 Net loss $ (140,362 ) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the Three Months Ended March 31, 2024 Cash flows from operating activities Net loss $ (145,825 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense 13,260 Decrease (increase) in assets: Inventory 175 Other current assets (45,544 ) Other assets 1,194 Increase (decrease) in liabilities: Accounts payable 4,370 Accrued expenses (10,131 ) Accrued interest on interCompany loans 39,997 Net cash used in operating activities (142,504 ) Cash flows from financing activities Proceeds received from interCompany loan 140,000 Net cash provided by financing activities 140,000 Effect of exchange rate changes on cash 4,648 Net increase (decrease) in cash 2,144 Cash - beginning 1,660 Cash - ending $ 3,804 Supplemental disclosures: Interest paid $ - Income taxes paid $ -

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 – Related Party Transactions Common Stock Issued as Consideration for Related Party Debt Modifications On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $ 724,086 March 1, 2027 10 7 Schedule of Related Party Debt Modifications Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Common Stock Issued for Services, Related Parties On June 15, 2023, the Company issued 1,500,000 89,850 On March 15, 2024, the Company issued shares of common stock to officers and directors for services provided, as listed below. The aggregate fair value of the common stock was $ 429,000 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2024
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 5 – Fair Value of Financial Instruments Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of March 31, 2024 and December 31, 2023, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at March 31, 2024 Level 1 Level 2 Level 3 Assets Cash $ 40,648 $ - $ - Total assets 40,648 - - Liabilities Convertible notes payable, related party Notes payable, related parties, net of $ 9,729 - 2,441,252 - Notes payable, net of $ 126,670 - 268,330 - Total liabilities - (2,709,582 ) - Fair Value, Net Asset (Liability) $ 40,648 $ (2,709,582 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 726 $ - $ - Total assets 726 - - Liabilities Convertible notes payable, related party - 750,000 - Notes payable, related parties - 1,146,500 - Notes payable, net of $ 24,136 - 310,864 - Total liabilities - (2,207,364 ) - Fair Value, Net Asset (Liability) $ 726 $ (2,207,364 ) $ - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the three months ended March 31, 2024 or the year ended December 31, 2023.

Inventory

Inventory	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventory	Note 6 – Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our CBD products consist entirely of finished goods. Inventory was $ 26,257 at March 31, 2024.

Security Deposits

Security Deposits	3 Months Ended
	Mar. 31, 2024
Security Deposits
Security Deposits	Note 7 – Security Deposits Security deposits consisted of refundable deposits on equipment purchases in the amount of $ 85,000

Accrued Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Accrued Expenses	Note 8 – Accrued Expenses Accrued expenses consisted of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Accrued Expenses March 31, December 31, 2024 2023 Accrued compensation $ 759,917 $ 665,417 Accrued interest 111,919 273,951 Accrued expenses $ 871,836 $ 939,368

Convertible Note Payable, Relat

Convertible Note Payable, Related Party	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Convertible Note Payable, Related Party	Note 9 – Convertible Note Payable, Related Party Convertible note payable, related party consists of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Convertible Note Payable Related Party March 31, December 31, 2024 2023 On September 27, 2022 - 750,000 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 September 16, 2024 8 15 750,000 90,740 March 1, 2027 7 9,017,000 595,122 $ - $ 750,000 Total convertible note payable, related party - 750,000 Less: current maturities - - Convertible note payable, related party, long-term portion $ - $ 750,000 The Company recorded interest expense pursuant to the stated interest rates on the convertible note, related party in the amount of $ 15,124 14,795 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Notes Payable, Related Parties

Notes Payable, Related Parties	3 Months Ended
	Mar. 31, 2024
Notes Payable Related Parties
Notes Payable, Related Parties	Note 10 – Notes Payable, Related Parties Notes payable, related parties, consists of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Notes Payable Related Party March 31, December 31, 2024 2023 On March 19, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 March 1, 2027 10 $ 50,000 $ - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 26,116 March 1, 2027 10 25,000 1,116 26,116 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 1,803,398 March 1, 2027 7 840,740 750,000 90,740 962,658 850,000 112,658 1,803,398 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 337,000 March 1, 2027 10 337,000 337,000 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 27,467 March 1, 2027 10 24,500 2,967 27,467 - On March 12, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 10 100,000 - On March 1, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 March 1, 2025 8 March 1, 2027 - - On February 26, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 27,000 10 27,000 - On January 29, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 January 29, 2025 8 March 1, 2027 - - On January 11, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,000 - On January 8, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,000 - On November 28, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 60,000 10 60,000 60,000 On October 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 25,000 10 March 1, 2027 - 25,000 On September 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 52,000 10 March 1, 2027 - 52,000 On August 31, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,000 6 March 1, 2027 - 4,000 On August 14, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 6,000 6 March 1, 2027 - 6,000 On August 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 6 March 1, 2027 - 50,000 On August 2, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,500 6 March 1, 2027 - 4,500 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 8 March 1, 2027 - 100,000 On July 7, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 5,000 6 March 1, 2027 - 5,000 On June 3, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 20,000 6 March 1, 2027 - 20,000 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 8 March 1, 2027 - 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 On December 29, 2021, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 Total notes payable, related parties 2,450,981 1,146,500 Less: unamortized debt discounts 9,729 - Notes payable, related parties, net of discounts 2,441,252 1,146,500 Less: current maturities - 1,146,500 Notes payable, related parties, long-term portion $ 2,441,252 $ - The Company recorded interest expense pursuant to the stated interest rates on the notes payable, related parties, in the amount of $ 29,686 5,467 110 On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $ 724,086 March 1, 2027 10% 7% Schedule of Consideration Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2024
Notes Payable
Notes Payable	Note 11 – Notes Payable Schedule of Notes Payable March 31, December 31, 2024 2023 On March 4, 2024, the Company completed the sale of a promissory note to the Sanguine Group, LLC (“Sanguine”) in the principal amount of $ 360,000 300,000 60,000 September 4, 2024 15 15,000 2,500,000 300,000 2,500,000 73,454 $ 360,000 $ - On August 18, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note of $ 35,000 10 15 35,000 35,000 On June 23, 2023, the Company completed the sale of a Promissory Note in the principal amount of $ 300,000 276,000 262,500 24,000 7,500 6,000 The Third AJB Note matured on March 23, 2024 12 10 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 100,000 1,666,667 42,175 In connection with the issuance of the Third AJB Note and Commitment Fee Shares, the Company entered into a Registration Rights Agreement with AJB Capital in which the Company agreed to file a registration statement with the SEC within 180 days of June 23, 2023, registering the shares of common stock issuable under the Third AJB Note and Purchase Agreement. The note was repaid on March 14, 2024 out of the proceeds received from the Sanguine Group Note. - 300,000 Total notes payable 395,000 335,000 Less: unamortized debt discounts 126,670 24,136 Notes payable, net of discounts 268,330 310,864 Less: current maturities 268,330 310,864 Notes payable, long-term portion $ - $ - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) The Company recognized aggregate debt discounts on the notes payable to for the three months ended March 31, 2024, as follows: Schedule of Notes Payable Debt Discounts March 31, December 31, 2024 2023 Fair value of commitment shares of common stock $ 73,454 $ 42,175 Original issue discounts 60,000 24,000 Legal and brokerage fees 15,000 13,500 Total debt discounts 148,454 79,675 Amortization of debt discounts 21,784 26,233 Unamortized debt discounts $ 126,670 $ 53,442 The aggregate debt discounts of $ 148,454 79,675 45,920 0 The convertible note limits the maximum number of shares that can be owned by the note holder as a result of the conversions to common stock to 4.99 The Company recorded interest expense pursuant to the stated interest rates on the notes payable in the amount of $ 11,250 37,808 The Company recognized interest expense for the three months ended March 31, 2024 and 2023, as follows: Schedule of Interest Expenses March 31, March 31, 2024 2023 Interest on convertible notes, related party $ 15,123 $ 14,795 Interest on notes payable, related parties 29,576 5,467 Interest on notes payable 11,250 37,808 Amortization of debt discounts, related parties 110 - Amortization of debt discounts, common stock 23,555 - Amortization of debt discounts 22,365 - Total interest expense $ 101,979 $ 58,070

Convertible Preferred Stock

Convertible Preferred Stock	3 Months Ended
	Mar. 31, 2024
Convertible Preferred Stock
Convertible Preferred Stock	Note 12 – Convertible Preferred Stock Preferred Stock The Company has 10,000,000 0.001 500,000 600,000 The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock. The Series A Preferred Stock accrues dividends at the rate of 6 99,733 238,501 10 15 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) The Series A and B Preferred Stock have been classified outside of permanent equity and liabilities. the Series A Preferred Stock embodies conditional obligations that the Company may settle by issuing a variable number of equity shares, and in both the Series A and B Preferred Stock, monetary value of the obligation is based on a fixed monetary amount known at inception. Preferred Stock Dividends The Series A Preferred Stock accrues dividends at the rate of 6 14,916 12,773 211,650

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13 – Commitments and Contingencies Equity Line of Credit On September 1, 2022, the Company entered into a Purchase Agreement (the “ELOC Purchase Agreement”) with Tysadco Partners, LLC (“Tysadco”). Pursuant to the ELOC Purchase Agreement, Tysadco has agreed to purchase from the Company, from time to time upon delivery by the Company to Tysadco of “Request Notices,” and subject to the other terms and conditions set forth in the ELOC Purchase Agreement, up to an aggregate of $ 10,000,000 The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice. In connection with the ELOC Purchase Agreement, the Company entered into a Registration Rights Agreement with Tysadco under which the Company agreed to file a registration statement with the Securities and Exchange Commission covering the shares of common stock issuable under the ELOC Purchase Agreement and conversion of the Commitment Fee Shares (the “Registration Rights Agreement”). There have not been any advances on this arrangement to date. Contingent Compensation On August 22, 2023, the Company entered into an advisor agreement with an individual to provide consulting and business advisory services to the Company. Pursuant to the agreement, the Company has agreed to compensate the consultant a fee of $ 5,000 5,000,000 200,000 On May 23, 2023, the Company appointed Joerg Sommer to be the Company’s President. In connection with his appointment, the Company entered into an offer letter with Mr. Sommer (the “Offer Letter”) under which he will initially be paid an annual base salary of $ 60,000 240,000 5,000,000 1,500,000 1,500,000 Mr. Sommer will also be entitled to a bonus of up $ 380,000 $ 200,000 2 $ 80,000 1 $ 60,000 1 $ 40,000 1 To date, the Company has not received gross proceeds pursuant to the Qualified Offering terms. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Changes in Stockholders_ Equity

Changes in Stockholders’ Equity	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Changes in Stockholders’ Equity	Note 14 – Changes in Stockholders’ Equity Common Stock The Company is authorized to issue an aggregate of 300,000,000 0.001 111,092,849 Common Stock Issued in Escrow Pursuant to Default Provisions of Debt Financing On March 4, 2024, the Company issue 10,394,610 Common Stock Issued as a Commitment Fee On March 19, 2024, the Company paid a commitment fee to Joerg Sommer, the Company’s President, in the form of 250,000 9,839 On March 4, 2024, the Company paid a commitment fee to The Sanguine Group, LLC in the form of 2,500,000 73,454 Common Stock Issued as Consideration for Related Party Debt Modifications On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $ 724,086 March 1, 2027 10 7 Schedule of Consideration For Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Common Stock Issued for Services, Related Parties On June 15, 2023, the Company issued 1,500,000 89,850 On March 15, 2024, the Company issued shares of common stock to officers and directors for services provided, as listed below. The aggregate fair value of the common stock was $ 429,000 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Common Stock Issued for Services On March 15, 2024, the Company issued an aggregate 500,000 33,000 On February 9, 2024, the Company issued 149,621 5,386 Common Stock Subscriptions Payable Issued for Services On March 31, 2024, the Company awarded 381,680 24,695 Amortization of Stock-Based Compensation A total of $ 3,852 38,130

Common Stock Options

Common Stock Options	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Common Stock Options	Note 15 – Common Stock Options Stock Incentive Plan On February 12, 2020, the Company’s stockholders approved our 2019 Stock Incentive Plan (the “2019 Plan”), which had been adopted by the Company’s Board of Directors (the “Board”) as of December 10, 2019. The 2019 Plan provides for the issuance of up to 10,000,000 Outstanding Options Options to purchase an aggregate total of 10,892,000 0.14 6.99 The Company recognized a total of $ 3,852 38,130 25,686

Warrants

Warrants	3 Months Ended
	Mar. 31, 2024
Warrants
Warrants	Note 16 – Warrants Outstanding Warrants Warrants to purchase an aggregate total of 14,011,650 0.29 1.66

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 17 – Income Taxes The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) For the three months ended March 31, 2024, and the year ended December 31, 2023, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At March 31, 2024, the Company had approximately $ 10,507,000 The net operating loss carry forwards, if not utilized, will begin to expire in 2025. Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at March 31, 2024 and December 31, 2023, respectively. In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 18 – Subsequent Events The Company evaluates events that have occurred after the balance sheet date through the date these financial statements were issued. SDT and AJB Debt Financings On April 19, 2024, the “Company completed the sale of a 12 1,300,000 1,196,000 300,000 276,000 The Notes mature on January 19, 2025 12 Pursuant to the Purchase Agreement with SDT, SDT received a pre-funded warrant to purchase 8,666,667 520,000 Pursuant to the Purchase Agreement with AJB, the Company paid a $ 120,000 2,000,000 360,000 257,446 207,000 50,446 Common Stock Issued as a Promissory Note Commitment On April 19, 2024, the Company paid a commitment fee to AJB Capital in the form of 2,000,000 41,417 Common Stock Issued for Services, Consultants On May 10, 2024, the Company issued 1,250,000 The fair value of the 76,250 On May 10, 2024, the Company issued 381,680 24,695

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Nature of Business	Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, the Company entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., a wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian Simplified Shares Company (“OWP SAS”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP SAS) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP SAS. OWP SAS is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). The Company plans to be a producer of and/or source raw and processed cannabis and hemp plant ingredients for both medical and industrial uses across the globe. The Company has received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, the Company is one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, the Company has entered into agreements with local farming cooperatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. The Company began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. OWP SAS has generated revenue since the second quarter of 2020. During the first quarter of 2022, the Company made payments of approximately $ 1,400,000 Bogot On December 22, 2023, OWP SAS, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. In connection with the Reorganization Proceedings, we paused production and sales of our cannabis operations in Colombia until the court overseeing the Reorganization Proceedings (the “Court”) provides the Company with a plan of reorganization, at which time the Company intends to resume operations and satisfy its obligations in Colombia in accordance with the Court’s plan. Furthermore, we continued our aggressive cost-cutting actions that included significant personnel reductions . Reorganization Proceedings Upon the date that the Proposed Plan, which is yet to be determined and remains subject to Court approval, becomes effective (the “Effective Date”), and subject to the effectiveness of the Proposed Plan, it is contemplated that the near term operations of the Company (also referred to as the “Post-Effective Date Debtors”) will consist of (a) claims administration under the Proposed Plan, (b) addressing the litigation, (c) prosecuting, pursuing, compromising, settling, or otherwise disposing of other retained causes of action, (d) defending the Company against any counterclaims, (e) attempting to realize value, if any, from our assets and (f) satisfying other regulatory requirements. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) In the future, the Post-Effective Date Debtors expect to explore potential business opportunities, including strategic partnerships, including those designed to maximize the Debtor’s assets, including restoration of the Company’s cannabis operations. No assurance can be made that the Proposed Plan will become effective or that we will be successful in prosecuting any claim or cause of action or that any strategic alternative will be identified and/or would result in profitable operations. In accordance with ASC 810-10-15, the Company has deconsolidated its foreign subsidiaries until it emerges from the Reorganization Proceedings to include the petitioning entity, OWP SAS, as well as the Company’s non-operating shell entities, Agrobase, S.A.S. and Hope Colombia, S.A.S., given the lack of independently identifiable operations. The deconsolidation resulted in a loss on deconsolidation of foreign subsidiaries in the amount of $ 97,672 1,564,823 During March of 2024, the Company, through OWP Ventures, began to sell a CBD-based therapeutic product in the United States in limited quantities.
Financial Reporting Under Reorganization	Financial Reporting Under Reorganization The Unaudited Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q have been prepared to reflect the application of Financial Accounting Standards Board, or “FASB” Accounting Standards Codification, or “ASC” 852, Reorganizations, protection under Colombian Law 1116 of 2006 Effective as of the Petition Date, the Company ceased recognizing interest income on intercompany loans made to the foreign subsidiaries. Subsequent loans advanced to, or payments made on behalf of these foreign subsidiaries, have been recognized as a loss on deconsolidation of foreign subsidiaries. In connection with the Company’s emergence from the bankruptcy protection under Colombian Law 1116 of 2006
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2024: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada.
Reclassifications	Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company is Colombian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Comprehensive Income	Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments.
Cash in Excess of FDIC Insured Limits	Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues in the current period consisted of the sale of our CBD rub, and in the prior period revenues consisted entirely of the sale of seeds. The sale of seeds included multi-element arrangements whereby the Company collected 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company had a right of first refusal to purchase products resulting from the harvest.
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In December 2023 , FASB issued “Income Taxes (Topic ): Improvements to Income Tax Disclosures,” , There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Common Control and Ownership Interest	The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2024: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.

Deconsolidation of Foreign Su_2

Deconsolidation of Foreign Subsidiaries (Tables)	3 Months Ended
	Mar. 31, 2024
Deconsolidation Of Foreign Subsidiaries
Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries	Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2024 2023 Assets Current assets: Cash $ 3,804 $ 1,660 Inventory 45,616 45,791 Other current assets 48,231 2,687 Total current assets 97,651 50,138 Other assets 225,348 226,542 Fixed assets, net 2,333,021 2,346,281 Total Assets $ 2,656,020 $ 2,622,961 Liabilities and Stockholders’ Equity (Deficit) Current liabilities: Accounts payable $ 396,773 $ 392,403 Accrued expenses 472,606 482,587 Notes payable 182,183 183,148 Intercompany liabilities owed to OWP Ventures, Inc. 7,528,031 7,348,034 Total current liabilities 8,579,593 8,406,172 Stockholders’ Equity (Deficit): Accumulated other comprehensive income 5,463 - Accumulated (deficit) (5,929,036 ) (5,783,211 ) Total Stockholders’ Equity (Deficit) (5,923,573 ) (5,783,211 ) Total Liabilities and Stockholders’ Equity (Deficit) $ 2,656,020 $ 2,622,961 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS For the Three Months Ended March 31, 2024 Operating expenses: General and administrative $ 77,866 Professional fees 14,966 Depreciation expense 13,260 Total operating expenses 106,092 Operating loss (106,092 ) Other income (expense): Interest expense (39,733 ) Total other expense (39,733 ) Net loss $ (145,825 ) Other comprehensive loss: Gain on foreign currency translation $ 5,463 Net loss $ (140,362 ) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the Three Months Ended March 31, 2024 Cash flows from operating activities Net loss $ (145,825 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense 13,260 Decrease (increase) in assets: Inventory 175 Other current assets (45,544 ) Other assets 1,194 Increase (decrease) in liabilities: Accounts payable 4,370 Accrued expenses (10,131 ) Accrued interest on interCompany loans 39,997 Net cash used in operating activities (142,504 ) Cash flows from financing activities Proceeds received from interCompany loan 140,000 Net cash provided by financing activities 140,000 Effect of exchange rate changes on cash 4,648 Net increase (decrease) in cash 2,144 Cash - beginning 1,660 Cash - ending $ 3,804 Supplemental disclosures: Interest paid $ - Income taxes paid $ -

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Debt Modifications	Schedule of Related Party Debt Modifications Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, All Other Investments [Abstract]
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis	The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of March 31, 2024 and December 31, 2023, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at March 31, 2024 Level 1 Level 2 Level 3 Assets Cash $ 40,648 $ - $ - Total assets 40,648 - - Liabilities Convertible notes payable, related party Notes payable, related parties, net of $ 9,729 - 2,441,252 - Notes payable, net of $ 126,670 - 268,330 - Total liabilities - (2,709,582 ) - Fair Value, Net Asset (Liability) $ 40,648 $ (2,709,582 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 726 $ - $ - Total assets 726 - - Liabilities Convertible notes payable, related party - 750,000 - Notes payable, related parties - 1,146,500 - Notes payable, net of $ 24,136 - 310,864 - Total liabilities - (2,207,364 ) - Fair Value, Net Asset (Liability) $ 726 $ (2,207,364 ) $ -

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Accrued Expenses March 31, December 31, 2024 2023 Accrued compensation $ 759,917 $ 665,417 Accrued interest 111,919 273,951 Accrued expenses $ 871,836 $ 939,368

Convertible Note Payable, Rel_2

Convertible Note Payable, Related Party (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Note Payable Related Party	Convertible note payable, related party consists of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Convertible Note Payable Related Party March 31, December 31, 2024 2023 On September 27, 2022 - 750,000 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 September 16, 2024 8 15 750,000 90,740 March 1, 2027 7 9,017,000 595,122 $ - $ 750,000 Total convertible note payable, related party - 750,000 Less: current maturities - - Convertible note payable, related party, long-term portion $ - $ 750,000

Notes Payable, Related Parties

Notes Payable, Related Parties (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Payable Related Parties
Schedule of Notes Payable Related Party	Notes payable, related parties, consists of the following at March 31, 2024 and December 31, 2023, respectively: Schedule of Notes Payable Related Party March 31, December 31, 2024 2023 On March 19, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 March 1, 2027 10 $ 50,000 $ - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 26,116 March 1, 2027 10 25,000 1,116 26,116 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 1,803,398 March 1, 2027 7 840,740 750,000 90,740 962,658 850,000 112,658 1,803,398 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 337,000 March 1, 2027 10 337,000 337,000 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 27,467 March 1, 2027 10 24,500 2,967 27,467 - On March 12, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 10 100,000 - On March 1, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 March 1, 2025 8 March 1, 2027 - - On February 26, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 27,000 10 27,000 - On January 29, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 January 29, 2025 8 March 1, 2027 - - On January 11, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,000 - On January 8, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,000 - On November 28, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 60,000 10 60,000 60,000 On October 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 25,000 10 March 1, 2027 - 25,000 On September 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 52,000 10 March 1, 2027 - 52,000 On August 31, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,000 6 March 1, 2027 - 4,000 On August 14, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 6,000 6 March 1, 2027 - 6,000 On August 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 6 March 1, 2027 - 50,000 On August 2, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,500 6 March 1, 2027 - 4,500 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 8 March 1, 2027 - 100,000 On July 7, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 5,000 6 March 1, 2027 - 5,000 On June 3, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 20,000 6 March 1, 2027 - 20,000 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 8 March 1, 2027 - 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 On December 29, 2021, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 Total notes payable, related parties 2,450,981 1,146,500 Less: unamortized debt discounts 9,729 - Notes payable, related parties, net of discounts 2,441,252 1,146,500 Less: current maturities - 1,146,500 Notes payable, related parties, long-term portion $ 2,441,252 $ -
Schedule of Consideration Related Party Debt	Schedule of Consideration Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Payable
Schedule of Notes Payable	Schedule of Notes Payable March 31, December 31, 2024 2023 On March 4, 2024, the Company completed the sale of a promissory note to the Sanguine Group, LLC (“Sanguine”) in the principal amount of $ 360,000 300,000 60,000 September 4, 2024 15 15,000 2,500,000 300,000 2,500,000 73,454 $ 360,000 $ - On August 18, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note of $ 35,000 10 15 35,000 35,000 On June 23, 2023, the Company completed the sale of a Promissory Note in the principal amount of $ 300,000 276,000 262,500 24,000 7,500 6,000 The Third AJB Note matured on March 23, 2024 12 10 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 100,000 1,666,667 42,175 In connection with the issuance of the Third AJB Note and Commitment Fee Shares, the Company entered into a Registration Rights Agreement with AJB Capital in which the Company agreed to file a registration statement with the SEC within 180 days of June 23, 2023, registering the shares of common stock issuable under the Third AJB Note and Purchase Agreement. The note was repaid on March 14, 2024 out of the proceeds received from the Sanguine Group Note. - 300,000 Total notes payable 395,000 335,000 Less: unamortized debt discounts 126,670 24,136 Notes payable, net of discounts 268,330 310,864 Less: current maturities 268,330 310,864 Notes payable, long-term portion $ - $ -
Schedule of Notes Payable Debt Discounts	The Company recognized aggregate debt discounts on the notes payable to for the three months ended March 31, 2024, as follows: Schedule of Notes Payable Debt Discounts March 31, December 31, 2024 2023 Fair value of commitment shares of common stock $ 73,454 $ 42,175 Original issue discounts 60,000 24,000 Legal and brokerage fees 15,000 13,500 Total debt discounts 148,454 79,675 Amortization of debt discounts 21,784 26,233 Unamortized debt discounts $ 126,670 $ 53,442
Schedule of Interest Expenses	The Company recognized interest expense for the three months ended March 31, 2024 and 2023, as follows: Schedule of Interest Expenses March 31, March 31, 2024 2023 Interest on convertible notes, related party $ 15,123 $ 14,795 Interest on notes payable, related parties 29,576 5,467 Interest on notes payable 11,250 37,808 Amortization of debt discounts, related parties 110 - Amortization of debt discounts, common stock 23,555 - Amortization of debt discounts 22,365 - Total interest expense $ 101,979 $ 58,070

Changes in Stockholders_ Equi_2

Changes in Stockholders’ Equity (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Schedule of Consideration For Related Party Debt	Schedule of Consideration For Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Schedule of Common Control and

Schedule of Common Control and Ownership Interest (Details)	3 Months Ended
	Mar. 31, 2024
Name of Entity	ONE WORLD PRODUCTS, INC.
State of incorporation	NV
One World Products, Inc. [Member]
Name of Entity	One World Products, Inc.	[1]
State of incorporation	NV	[1]
Relationship	Parent	[1]
OWP Ventures, Inc. [Member]
Name of Entity	OWP Ventures, Inc.	[2]
State of incorporation	DE	[2]
Relationship	Subsidiary	[2]
[1]Holding company in the form of a corporation.[2]Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended			12 Months Ended
	Feb. 21, 2019	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Loss on deconsolidation of foreign subsidiaries		$ 97,672			$ 1,564,823
FDIC insured amount		250,000
Cash uninsured amount		$ 0
Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share based payment award shares purchased	825,000
Share price	$ 0.50
Merger Agreement [Member] | OWP Ventures, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business acquisition, equity interest issued or issuable, number of shares	39,475,398
Share based payment award shares purchased	825,000
Share price	$ 0.50
Proceeds from convertible debt	$ 300,000
Conversion price	$ 0.424
Common stock shares cancelled	875,000
Payments to Acquire Machinery and Equipment				$ 1,400,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash on hand	$ 40,648	$ 726
Working capital	1,871,931
Accumulated deficit	$ 28,630,708	$ 26,929,686

Schedule of Deconsolidated Bala

Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 40,648		$ 726
Inventory	26,257
Total current assets	98,841		13,882
Total Assets	183,841		98,882
Current liabilities:
Accounts payable	618,956		528,645
Accrued expenses	871,836		939,368
Total current liabilities	1,970,772		3,872,111
Stockholders’ Equity (Deficit):
Accumulated other comprehensive income			42,328
Accumulated (deficit)	(28,630,708)		(26,929,686)
Total Stockholders’ Equity (Deficit)	(8,803,028)	$ (5,841,870)	(8,348,074)	$ (5,836,258)
Total Liabilities and Stockholders’ Equity (Deficit)	183,841		98,882
Operating expenses:
General and administrative	198,847	347,297
Professional fees	578,671	103,848
Depreciation expense		7,857
Total operating expenses	777,518	459,002
Operating loss	(777,285)	(457,868)
Other income (expense):
Interest expense	(101,979)	(58,070)
Total other expense	(923,737)	(58,070)
Net loss	(1,701,022)	(515,938)
Other comprehensive loss:
Gain on foreign currency translation	(42,328)	184,969
Net other comprehensive loss	(1,743,350)	(330,969)
Cash flows from operating activities
Net loss	(1,701,022)	(515,938)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense		7,857
Decrease (increase) in assets:
Inventory	(26,257)	(225,037)
Other current assets	(18,498)	(27,353)
Other assets		(7,023)
Increase (decrease) in liabilities:
Accounts payable	90,311	(50,344)
Accrued expenses	139,949	171,267
Net cash used in operating activities	(249,750)	(561,983)
Cash flows from financing activities
Net cash provided by financing activities	332,000	450,000
Effect of exchange rate changes on cash	(42,328)	190,722
Net increase (decrease) in cash	39,922	73,693
Cash - beginning	726	11,016
Cash - ending	40,648	84,709
Supplemental disclosures:
Interest paid	10,500	22,192
Income taxes paid
Subsidiaries [Member]
Current assets:
Cash	3,804		1,660
Inventory	45,616		45,791
Other current assets	48,231		2,687
Total current assets	97,651		50,138
Other assets	225,348		226,542
Fixed assets, net	2,333,021		2,346,281
Total Assets	2,656,020		2,622,961
Current liabilities:
Accounts payable	396,773		392,403
Accrued expenses	472,606		482,587
Notes payable	182,183		183,148
Intercompany liabilities owed to OWP Ventures, Inc.	7,528,031		7,348,034
Total current liabilities	8,579,593		8,406,172
Stockholders’ Equity (Deficit):
Accumulated other comprehensive income	5,463
Accumulated (deficit)	(5,929,036)		(5,783,211)
Total Stockholders’ Equity (Deficit)	(5,923,573)		(5,783,211)
Total Liabilities and Stockholders’ Equity (Deficit)	2,656,020		$ 2,622,961
Operating expenses:
General and administrative	77,866
Professional fees	14,966
Depreciation expense	13,260
Total operating expenses	106,092
Operating loss	(106,092)
Other income (expense):
Interest expense	(39,733)
Total other expense	(39,733)
Net loss	(145,825)
Other comprehensive loss:
Gain on foreign currency translation	5,463
Net other comprehensive loss	(140,362)
Cash flows from operating activities
Net loss	(145,825)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	13,260
Decrease (increase) in assets:
Inventory	175
Other current assets	(45,544)
Other assets	1,194
Increase (decrease) in liabilities:
Accounts payable	4,370
Accrued expenses	(10,131)
Accrued interest on interCompany loans	39,997
Net cash used in operating activities	(142,504)
Cash flows from financing activities
Proceeds received from interCompany loan	140,000
Net cash provided by financing activities	140,000
Effect of exchange rate changes on cash	4,648
Net increase (decrease) in cash	2,144
Cash - beginning	1,660
Cash - ending	3,804
Supplemental disclosures:
Interest paid
Income taxes paid

Deconsolidation of Foreign Su_3

Deconsolidation of Foreign Subsidiaries (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Dec. 22, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Deconsolidation Of Foreign Subsidiaries
Financial obligations	$ 1,200,000
Loss on deconsolidation of foreign subsidiaries		$ 97,672		$ 1,564,823

Schedule of Related Party Debt

Schedule of Related Party Debt Modifications (Details)	Mar. 15, 2024 USD ($) shares
Related Party Transaction [Line Items]
Aggregate debts extended	$ 2,193,981
Shares | shares	10,971,000
Fair value	$ 724,086
Isiah Thomas III [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 27,467
Shares | shares	138,000
Fair value	$ 9,108
Dr.Kenneth Perego II [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 337,000
Shares | shares	1,685,000
Fair value	$ 111,210
Mr Joerg Sommer [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 26,116
Shares | shares	131,000
Fair value	$ 8,646
Dr John McCabe [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 1,803,398
Shares | shares	9,017,000
Fair value	$ 595,122

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)				3 Months Ended
	May 15, 2024	Mar. 15, 2024	Jun. 15, 2023	Mar. 31, 2024	Mar. 31, 2023
Related Party Transaction [Line Items]
Aggregate fair value of the common stock		$ 724,086
Maturity date		Mar. 01, 2027
Interest rate		10%
Interest rate percentage		7%
Shares			1,500,000
Aggregate fair value of the common stock			$ 89,850	$ 492,081
Aggregate fair value of the common stock					$ 300,000
Fair value		$ 724,086
Isiah Thomas III [Member]
Related Party Transaction [Line Items]
Fair value		9,108
Dr.Kenneth Perego II [Member]
Related Party Transaction [Line Items]
Fair value		111,210
Mr Joerg Sommer [Member]
Related Party Transaction [Line Items]
Fair value		$ 8,646
Common Stock [Member]
Related Party Transaction [Line Items]
Shares		6,500,000		7,149,621
Aggregate fair value of the common stock				$ 7,150
Aggregate fair value of the common stock					$ 3,000
Fair value		$ 429,000
Common Stock [Member] | Isiah Thomas III [Member]
Related Party Transaction [Line Items]
Shares		2,000,000
Fair value		$ 132,000
Common Stock [Member] | Dr.Kenneth Perego II [Member]
Related Party Transaction [Line Items]
Shares		2,000,000
Fair value		$ 132,000
Common Stock [Member] | Terry Buffalo [Member]
Related Party Transaction [Line Items]
Shares		2,000,000
Fair value		$ 132,000
Common Stock [Member] | Mr Joerg Sommer [Member]
Related Party Transaction [Line Items]
Shares		500,000
Fair value		$ 33,000
Officers and Directors [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Aggregate fair value of the common stock	$ 429,000	$ 429,000

Schedule of Valuation of Financ

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash	$ 40,648	$ 726
Fair Value, Inputs, Level 1 [Member]
Assets
Cash	40,648	726
Total assets	40,648	726
Liabilities
Convertible notes payable, related party
Notes payable, related parties
Notes payable, net of $24,136 of debt discounts
Total liabilities
Fair Value, Net Asset (Liability)	40,648	726
Fair Value, Inputs, Level 2 [Member]
Assets
Cash
Total assets
Liabilities
Convertible notes payable, related party		750,000
Notes payable, related parties	2,441,252	1,146,500
Notes payable, net of $24,136 of debt discounts	268,330	310,864
Total liabilities	(2,709,582)	(2,207,364)
Fair Value, Net Asset (Liability)	(2,709,582)	(2,207,364)
Fair Value, Inputs, Level 3 [Member]
Assets
Cash
Total assets
Liabilities
Convertible notes payable, related party
Notes payable, related parties
Notes payable, net of $24,136 of debt discounts
Total liabilities
Fair Value, Net Asset (Liability)

Schedule of Valuation of Fina_2

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) (Parenthetical) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Net of debt discount	$ 126,670	$ 24,136
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Net of debt discount	$ 9,729

Inventory (Details Narrative)

Inventory (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventory, net	$ 26,257

Security Deposits (Details Narr

Security Deposits (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Security Deposits
Security deposits	$ 85,000	$ 85,000

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued compensation	$ 759,917	$ 665,417
Accrued interest	111,919	273,951
Accrued expenses	$ 871,836	$ 939,368

Schedule of Convertible Note Pa

Schedule of Convertible Note Payable Related Party (Details) - Convertible Debt [Member] - Related Party [Member] - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Total convertible note payable, related party		$ 750,000
Less: current maturities
Convertible note payable, related party, long-term portion		750,000
Promissory Note [Member]
Short-Term Debt [Line Items]
Total convertible note payable, related party		$ 750,000

Schedule of Convertible Note _2

Schedule of Convertible Note Payable Related Party (Details) (Parenthetical) - USD ($)			3 Months Ended	12 Months Ended
	Mar. 15, 2024	Sep. 27, 2022	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Interest rate	7%
Aggregate fair value of the common stock			$ 21,784	$ 26,233
Promissory Note [Member] | John McCabe Investments LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 750,000	$ 750,000
Maturity date	Mar. 01, 2027	Sep. 16, 2024
Interest rate	7%	8%
Accrued interest	$ 90,740
Issuance of common stock	9,017,000
Aggregate fair value of the common stock	$ 595,122
Promissory Note [Member] | John McCabe Investments LLC [Member] | Series B Common Stock [Member]
Short-Term Debt [Line Items]
Conversion price		$ 15

Convertible Note Payable, Rel_3

Convertible Note Payable, Related Party (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Short-Term Debt [Line Items]
Interest expenses of convertible note	$ 15,123	$ 14,795
Convertible Debt [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Interest expenses of convertible note	$ 15,124	$ 14,795

Schedule of Notes Payable Relat

Schedule of Notes Payable Related Party (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Total notes payable, related parties	$ 395,000	$ 335,000
Less: unamortized debt discounts	9,729
Notes payable, related parties, long-term portion	2,441,252	1,146,500
Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, long-term portion	2,441,252
Less: current maturities		1,146,500
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	360,000
Unsecured Promissory Note One [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	50,000
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	35,000	35,000
Unsecured Promissory Note Two [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	26,116
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		300,000
Unsecured Promissory Note Three [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	1,803,398
Unsecured Promissory Note Four [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	337,000
Unsecured Promissory Note Five [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	27,467
Unsecured Promissory Note Six [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	100,000
Unsecured Promissory Note Seven [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties
Unsecured Promissory Note Eight [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	27,000
Unsecured Promissory Note Nine [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties
Unsecured Promissory Note Ten [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	10,000
Unsecured Promissory Note Eleven [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	10,000
Unsecured Promissory Note Twelve [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	60,000	60,000
Unsecured Promissory Note Thirteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		25,000
Unsecured Promissory Note Fourteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		52,000
Unsecured Promissory Note Fifteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		4,000
Unsecured Promissory Note Sixteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		6,000
Unsecured Promissory Note Seventeen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		50,000
Unsecured Promissory Note Eighteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		4,500
Unsecured Promissory Note Nineteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		100,000
Unsecured Promissory Note Twenty [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		5,000
Unsecured Promissory Note Twenty One [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		10,000
Unsecured Promissory Note Twenty Two [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		10,000
Unsecured Promissory Note Twenty Three [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		20,000
Unsecured Promissory Note Twenty Four [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		400,000
Unsecured Promissory Note Twenty Five [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		200,000
Unsecured Promissory Note Twenty Six [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties		200,000
Unsecured Promissory Notes [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable, related parties	$ 2,450,981	$ 1,146,500

Schedule of Notes Payable Rel_2

Schedule of Notes Payable Related Party (Details) (Parenthetical) - USD ($)	Mar. 19, 2024	Mar. 15, 2024	Mar. 01, 2024	Jan. 29, 2024	Oct. 11, 2023	Sep. 11, 2023	Aug. 31, 2023	Aug. 14, 2023	Aug. 05, 2022	Aug. 02, 2022	Jul. 07, 2022	Jun. 13, 2022	Jun. 03, 2022	May 05, 2022	Mar. 01, 2022	Feb. 15, 2022	Dec. 29, 2021	Mar. 12, 2024	Feb. 26, 2024	Jan. 11, 2024	Jan. 08, 2024	Nov. 28, 2023
Interest rate		7%
Unsecured Promissory Note [Member] | Joerg Sommer [Member]
Debt instrument, face value		$ 25,000
Accrued interest		1,116
Unsecured Promissory Note [Member] | Dr.Kenneth Perego II [Member]
Debt instrument, face value		337,000
Unsecured Promissory Note [Member] | Isiah Thomas III [Member]
Debt instrument, face value		24,500
Accrued interest		2,967
Unsecured Promissory Note [Member] | Joerg Sommer [Member]
Debt instrument, face value	$ 50,000	$ 26,116			$ 25,000
Maturity date	Mar. 01, 2027	Mar. 01, 2027			Mar. 01, 2027
Interest rate	10%	10%			10%
Unsecured Promissory Note [Member] | John McCabe Investments LLC [Member]
Debt instrument, face value		$ 1,803,398	$ 100,000	$ 50,000								$ 100,000			$ 400,000	$ 200,000
Maturity date		Mar. 01, 2027	Mar. 01, 2025	Jan. 29, 2025								Mar. 01, 2027			Mar. 01, 2027	Mar. 01, 2027
Interest rate		7%	8%	8%								8%			8%	8%
Unsecured Promissory Note [Member] | Dr.Kenneth Perego II [Member]
Debt instrument, face value		$ 337,000				$ 52,000	$ 4,000	$ 6,000	$ 50,000		$ 5,000			$ 20,000			$ 200,000	$ 100,000	$ 27,000	$ 10,000	$ 10,000	$ 60,000
Maturity date		Mar. 01, 2027				Mar. 01, 2027	Mar. 01, 2027	Mar. 01, 2027	Mar. 01, 2027		Mar. 01, 2027			Mar. 01, 2027			Mar. 01, 2027
Interest rate		10%				10%	6%	6%	6%		6%			6%			8%	10%	10%	10%	10%	10%
Unsecured Promissory Note [Member] | Isiah Thomas III [Member]
Debt instrument, face value		$ 27,467								$ 4,500			$ 10,000	$ 10,000
Maturity date		Mar. 01, 2027								Mar. 01, 2027			Mar. 01, 2027	Mar. 01, 2027
Interest rate		10%								6%			6%	6%
Unsecured Promissory Note One [Member] | John McCabe Investments LLC [Member]
Debt instrument, face value		$ 750,000
Accrued interest		90,740
Unsecured Promissory Note One [Member] | John McCabe Investments LLC [Member]
Debt instrument, face value		840,740
Unsecured Promissory Note Two [Member] | John McCabe Investments LLC [Member]
Debt instrument, face value		850,000
Accrued interest		112,658
Unsecured Promissory Note Two [Member] | John McCabe Investments LLC [Member]
Debt instrument, face value		$ 962,658
Maturity date		Mar. 01, 2027

Schedule of Consideration Relat

Schedule of Consideration Related Party Debt (Details)	Mar. 15, 2024 USD ($) shares
Defined Benefit Plan Disclosure [Line Items]
Aggregate debts extended	$ 2,193,981
Shares | shares	10,971,000
Fair value	$ 724,086
Isiah Thomas III [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate debts extended	$ 27,467
Shares | shares	138,000
Fair value	$ 9,108
Dr.Kenneth Perego II [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate debts extended	$ 337,000
Shares | shares	1,685,000
Fair value	$ 111,210
Mr Joerg Sommer [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate debts extended	$ 26,116
Shares | shares	131,000
Fair value	$ 8,646
Dr John McCabe [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate debts extended	$ 1,803,398
Shares | shares	9,017,000
Fair value	$ 595,122

Notes Payable, Related Partie_2

Notes Payable, Related Parties (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 15, 2024
Defined Benefit Plan Disclosure [Line Items]
Interest expense	$ 101,979	$ 58,070
Amortization of debt discounts	110
Additional collateral, aggregate fair value			$ 724,086
Investment maturity date			Mar. 01, 2027
Interest rate			10%
Debt interest rate			7%
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Interest expense	$ 29,686	$ 5,467

Schedule of Notes Payable (Deta

Schedule of Notes Payable (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Total notes payable	$ 395,000	$ 335,000
Less: unamortized debt discounts	126,670	24,136
Notes payable, long-term portion	2,441,252	1,146,500
Nonrelated Party [Member]
Short-Term Debt [Line Items]
Notes payable, net of discounts	268,330	310,864
Less: current maturities	268,330	310,864
Notes payable, long-term portion
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable	360,000
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable	35,000	35,000
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable		$ 300,000

Schedule of Notes Payable (De_2

Schedule of Notes Payable (Details) (Parenthetical)				3 Months Ended		12 Months Ended
	Mar. 04, 2024 USD ($) shares	Jun. 23, 2023 USD ($) Integer shares	Jun. 15, 2023 shares	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Mar. 15, 2024	Aug. 18, 2023 USD ($)
Short-Term Debt [Line Items]
purchase price				$ 347,000
Original issue discount				126,670		$ 53,442
Debt interest rate							7%
Number of stock issued for commitment fee | shares			1,500,000
Debt discount amortized				$ 21,784		$ 26,233
Unsecured Promissory Note One [Member] | Sangnine Group LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument face amount	$ 360,000
purchase price	300,000
Original issue discount	$ 60,000
Debt instrument maturity date	Sep. 04, 2024
Debt interest rate	15%
Legal fees	$ 15,000
Number of stock issued for commitment fee | shares	2,500,000
Debt discount amortized	$ 73,454
Unsecured Promissory Note One [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument face amount	$ 300,000
Unsecured Promissory Note Two [Member] | LDL8 Consulting LLC [Member]
Short-Term Debt [Line Items]
Debt instrument face amount								$ 35,000
Debt interest rate								10%
Increase in interest rate								15%
Unsecured Promissory Note Three [Member] | AJB Capital Investments LLC [Member]
Short-Term Debt [Line Items]
Debt instrument maturity date		Mar. 23, 2024
Debt interest rate		12%
Number of stock issued for commitment fee | shares		1,666,667
Debt discount amortized		$ 42,175
Trading days | Integer		10
Debt instrument commitment fee paid		$ 100,000
Unsecured Promissory Note Three [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument face amount		300,000
purchase price		276,000
Original issue discount		24,000
Legal fees		7,500
Net proceeds		262,500
Brokerage fees		$ 6,000

Schedule of Notes Payable Debt

Schedule of Notes Payable Debt Discounts (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Notes Payable
Fair value of commitment shares of common stock	$ 73,454		$ 42,175
Original issue discounts	60,000		24,000
Legal and brokerage fees	15,000		13,500
Total debt discounts	148,454	$ 79,675	79,675
Amortization of debt discounts	21,784		26,233
Unamortized debt discounts	$ 126,670		$ 53,442

Schedule of Interest Expenses (

Schedule of Interest Expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Notes Payable
Interest on convertible notes, related party	$ 15,123	$ 14,795
Interest on notes payable, related parties	29,576	5,467
Interest on notes payable	11,250	37,808
Amortization of debt discounts, related parties	110
Amortization of debt discounts, common stock	23,555
Amortization of debt discounts	22,365
Total interest expense	$ 101,979	$ 58,070

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Short-Term Debt [Line Items]
Amortization of debt discount	$ 148,454	$ 79,675	$ 79,675
Finance expense	$ 45,920	0
Common stock percentage	4.99%
Interest expense	$ 15,123	14,795
Notes Payable [Member]
Short-Term Debt [Line Items]
Interest expense	$ 11,250	$ 37,808

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Preferred stock, shares authorized	9,200,000		9,200,000
Dividend rate percentage	6%
Preferred stock dividend recognized	$ 14,916	$ 12,773
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized	10,000,000
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock shares designated	$ 500,000
Conversion of preferred stock into common stock, description	The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock. The Series A Preferred Stock accrues dividends at the rate of 6% per annum, payable in cash as and when declared by the Board or upon a liquidation.
Dividend rate percentage	6%
Series A convertible preferred stock, issued	99,733		70,233
Series A convertible preferred stock, outstanding	99,733		70,233
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock shares designated	$ 600,000
Series A convertible preferred stock, issued	238,501		272,168
Series A convertible preferred stock, outstanding	238,501		272,168
Series A Preferred Stock [Member]
Preferred stock, par value	$ 10
Series A convertible preferred stock, issued	99,733
Series A convertible preferred stock, outstanding	99,733
Dividends, Preferred Stock, Cash	$ 211,650
Series B Preferred Stock [Member]
Preferred stock, par value	$ 15
Series A convertible preferred stock, issued	238,501
Series A convertible preferred stock, outstanding	238,501

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)					3 Months Ended
	Aug. 22, 2023	May 23, 2023	May 22, 2023	Sep. 01, 2022	Mar. 31, 2023
Aggregate number common stock sold for cash					$ 300,000
Scenario One [Member]
Gross proceeds		$ 2,000,000
Sale of equity		200,000
Scenario Two [Member]
Gross proceeds		1,000,000
Sale of equity		80,000
Scenario Three [Member]
Gross proceeds		1,000,000
Sale of equity		60,000
Scenario Four [Member]
Gross proceeds		1,000,000
Sale of equity		40,000
President [Member]
Gross proceeds		5,000,000
Annual base salary		$ 240,000	$ 60,000
Shares issued		1,500,000
Shares issued		$ 380,000
Common Stock [Member]
Aggregate number common stock sold for cash					$ 3,000
Advisor Agreement [Member]
Consultation fee	$ 5,000
Gross proceeds	5,000,000
Advisor cash bonus	$ 200,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member]
Aggregate number common stock sold for cash				$ 10,000,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member] | Common Stock [Member]
Common stock, conversion basis				The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice.

Schedule of Consideration For R

Schedule of Consideration For Related Party Debt (Details) - USD ($)			3 Months Ended
	Mar. 15, 2024	Jun. 15, 2023	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended	$ 2,193,981
Shares	10,971,000
Fair value	$ 724,086
Shares		1,500,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value	$ 429,000
Shares	6,500,000		7,149,621
Isiah Thomas III [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended	$ 27,467
Shares	138,000
Fair value	$ 9,108
Isiah Thomas III [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value	$ 132,000
Shares	2,000,000
Dr.Kenneth Perego II [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended	$ 337,000
Shares	1,685,000
Fair value	$ 111,210
Dr.Kenneth Perego II [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value	$ 132,000
Shares	2,000,000
Mr Joerg Sommer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended	$ 26,116
Shares	131,000
Fair value	$ 8,646
Mr Joerg Sommer [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value	$ 33,000
Shares	500,000
Dr John McCabe [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended	$ 1,803,398
Shares	9,017,000
Fair value	$ 595,122
Terry Buffalo [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value	$ 132,000
Shares	2,000,000

Changes in Stockholders_ Equi_3

Changes in Stockholders’ Equity (Details Narrative) - USD ($)								3 Months Ended
	May 15, 2024	Mar. 31, 2024	Mar. 19, 2024	Mar. 15, 2024	Mar. 04, 2024	Feb. 09, 2024	Jun. 15, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized		300,000,000						300,000,000		300,000,000
Common stock, par value		$ 0.001						$ 0.001		$ 0.001
Common stock, shares issued		111,092,849						111,092,849		79,827,618
Common stock, shares outstanding		111,092,849						111,092,849		79,827,618
Common stock issued for services, shares							1,500,000
Common stock sold for cash									$ 300,000
Number of shares for service, value							$ 89,850	$ 492,081
Additional collateral, aggregate fair value				$ 724,086
Investment maturity date				Mar. 01, 2027
Interest rate				10%
Debt interest rate				7%
Amortization of common stock options issued for services								$ 3,852	$ 38,130
Promissory Note [Member] | Sanguine Group Llc [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares			2,500,000
Number of shares for service, value			$ 73,454
Promissory Note [Member] | Mr Joerg Sommer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares			250,000
Common stock sold for cash			$ 9,839
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issued					10,394,610				3,000,000
Common stock issued for services, shares				6,500,000				7,149,621
Common stock sold for cash									$ 3,000
Number of shares for service, value								$ 7,150
Common Stock [Member] | Two Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares				500,000
Number of shares for service, value				$ 33,000
Common Stock [Member] | ClearThink Capital Partners LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares		381,680				149,621
Number of shares for service, value		$ 24,695				$ 5,386
Common Stock [Member] | Mr Joerg Sommer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issued							1,500,000
Common stock sold for cash							$ 89,850
Common Stock [Member] | Officers and Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash	$ 429,000			$ 429,000

Common Stock Options (Details N

Common Stock Options (Details Narrative) - USD ($)		3 Months Ended
	Feb. 12, 2020	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average strike price		$ 0.14
Weighted average life		6 years 11 months 26 days
Stock-based compensation		$ 3,852	$ 38,130
2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares		10,892,000
Board of Directors [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock sold for cash, shares	10,000,000
Officers Directors and Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unamortized debt issuance expense		$ 25,686

Warrants (Details Narrative)

Warrants (Details Narrative)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Warrants
Warrants to purchase of common stock | shares	14,011,650
Warrants, weighted average strike price | $ / shares	$ 0.29
Weighted average term	1 year 7 months 28 days

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)
Income Tax Disclosure [Abstract]
Federal net operating losses	$ 10,507,000
Net operating loss carry forwards expiration	The net operating loss carry forwards, if not utilized, will begin to expire in 2025.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)								3 Months Ended
	May 10, 2024	Apr. 19, 2024	Mar. 31, 2024	Mar. 15, 2024	Mar. 04, 2024	Feb. 09, 2024	Jun. 15, 2023	Mar. 31, 2024	Mar. 31, 2023
Subsequent Event [Line Items]
Interest rate percentage				7%
Common stock issued for services, shares							1,500,000
Common Stock issued for services							$ 89,850	$ 492,081
Common stock sold for cash									$ 300,000
Common Stock [Member]
Subsequent Event [Line Items]
Common stock issued for services, shares				6,500,000				7,149,621
Common Stock issued for services								$ 7,150
Common stock sold for cash, shares					10,394,610				3,000,000
Common stock sold for cash									$ 3,000
ClearThink Capital Partners LLC [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Common stock issued for services, shares			381,680			149,621
Common Stock issued for services			$ 24,695			$ 5,386
Subsequent Event [Member]
Subsequent Event [Line Items]
Debt Instrument, Maturity Date		Jan. 19, 2025
Interest rate percentage		12%
Common stock issued for services, shares	1,250,000
Common Stock issued for services	$ 76,250
Subsequent Event [Member] | Pre Funded Warrant [Member]
Subsequent Event [Line Items]
Shares, Issued		8,666,667
Proceeds from Issuance of Warrants		$ 520,000
Subsequent Event [Member] | SDT Equities LLC [Member]
Subsequent Event [Line Items]
Sale of stock, percentage of ownership after transaction		12%
Debt instrument, face amount		$ 1,300,000
Sale of stock consideration received		1,196,000
Subsequent Event [Member] | AJB Capital Investments LLC [Member]
Subsequent Event [Line Items]
Debt instrument, face amount		300,000
Sale of stock consideration received		276,000
Line of credit facility, commitment fee amount		$ 120,000
Commitment fee shares		2,000,000
Repayments of debt		$ 360,000
Subsequent Event [Member] | AJB Capital Investments LLC [Member] | Promissory Note [Member]
Subsequent Event [Line Items]
Common stock issued for services, shares		2,000,000
Common Stock issued for services		$ 41,417
Subsequent Event [Member] | AJB Capital Investments LLC [Member] | Dr.Kenneth Perego II [Member]
Subsequent Event [Line Items]
Repayments of debt		207,000
Debt instrument, fee amount		257,446
Debt aggregate interest rate		$ 50,446
Subsequent Event [Member] | ClearThink Capital Partners LLC [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Common stock sold for cash, shares	381,680
Common stock sold for cash	$ 24,695